In an old candy factory, not far from the Massachusetts Institute of Technology (Cambridge, USA), Yi Yang sits in front of a laminar flow hood to manipulate a transparent tray. Submerged in a fuchsia fluid, millions of tumor cells are expected to be manipulated with fashion technology in laboratories around the world, CRISPR, a kind of genetic editing that has also been put to the service of Oncology.

At this Novartis Basic Research Institute in Boston (NBIR) there is no longer a trace of candy sugar on the walls. Now everything looks aseptic and glazed in this center to which the company has invited a group of journalists from around the world on the occasion of the World Medical Innovation Forum that is celebrated this week in Boston. More information.